Molecular Mechanisms of Action and Potential Biomarkers of Growth Inhibition of Dasatinib (BMS-354825) on Hepatocellular Carcinoma Cells

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-13-267
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Molecular Mechanism of Action and Potential Biomarkers of Growth Inhibition of Synergistic Combination of Afatinib and Dasatinib Against Gefitinib-Resistant Non-Small Cell Lung Cancer Cells

Oncotarget
Oncology
2018English

mTOR Inhibition Reduces Growth and Adhesion of Hepatocellular Carcinoma Cells In�vitro

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Micro-Ribonucleic Acids: Potential Noninvasive Biomarkers for Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma
2014English

New and Old Biomarkers of Hepatocellular Carcinoma

Hepatoma Research
2018English

Hepatocellular Carcinoma; Biomarkers: A Molecular Approach for Early Detection

THE PROFESSIONAL MEDICAL JOURNAL
2016English

A Quantitative Proteomic Approach for Identification of Potential Biomarkers in Hepatocellular Carcinoma

Journal of Proteome Research
BiochemistryChemistry
2008English

Updated Study on Action Mechanisms of Cereblon as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

HPB
HepatologyGastroenterology
2019English

Circulating Tumour Cells as Biomarkers for Evaluating Cryosurgery on Unresectable Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2016English

Mechanisms of Alcohol-Induced Hepatocellular Carcinoma

Hepatology International
Hepatology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy